Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2026-02-25 @ 9:47 PM
Study NCT ID:
NCT06343935
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YY-20394-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None